Table 2 Main clinical cardiovascular risk factors of patients with or without patency failure of percutaneous transluminal angioplasty.
| With failure (n = 29) | Without failure (n = 53) | p Value | |
|---|---|---|---|
| Age (years) | 61.45 (10.08) | 62.19 (10.99) | 0.765 |
| Gender (male/female) | 10/19 | 22/31 | 0.533 |
| Hypertension | 10 | 34 | 0.010 |
| Diabetes | 14 | 23 | 0.671 |
| Cholesterol (mg/l) | 170.72 (34.02) | 177.26 (41.27) | 0.469 |
| 4.41 (0.89) | 4.58 (1.07) | ||
| Aspirin use | 6 | 13 | 0.694 |
| Current smoker | 3 | 17 | 0.033 |
| I‐PTH (pg/ml) | 197.50 (219.39) | 173.28 (187.16) | 0.600 |
| Ca–P | 53.03 (16.45) | 44.95 (15.95) | 0.033 |
| URR (%) | 78.08 (7.04) | 72.81 (5.60) | <0.001 |
| Albumin (g/dl) | 3.02 (0.21) | 3.43 (0.37) | <0.001 |
Ca–P, calcium–phosphate product; I‐PTH, intact parathyroid hormone; URR, urea reduction ratio.
Data are shown as number or mean (SD), as appropriate.
The Student's t test is used for continuous data analysis, and χ2 test or Fisher's exact test for categorical data analysis as appropriate.